Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asad Bashey

Showing results (31-40 of 128) with videos related to

Pageof 13
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 12, 2015
Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors: A Multivariable Analysis Including Disease Risk IndexAsad Bashey, Xu Zhang, Katelin Jackson, et al.
Blood Advances|October 27, 2020
Class II HLA mismatch improves outcomes following haploidentical transplantation with posttransplant cyclophosphamideScott R Solomon, Michael T Aubrey, Xu Zhang, et al.
Bone Marrow Transplantation|March 11, 2018
Comparison of outcomes following transplantation with T-replete HLA-haploidentical donors using post-transplant cyclophosphamide to matched related and unrelated donors for patients with AML and MDS aged 60 years or olderZain A Bashey, Xu Zhang, Stacey Brown, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2015
Corticosteroid-Free Primary Treatment of Chronic Extensive Graft-versus-Host Disease Incorporating RituximabScott R Solomon, Connie A Sizemore, Michelle Ridgeway, et al.
Transplantation and Cellular Therapy|May 22, 2022
High-Dose Bendamustine, Etoposide, Cytarabine, and Melphalan (BeEAM) Conditioning Before Autologous Transplantation for Patients With Multiple MyelomaScott R Solomon, Stacey Brown, Nancy Shegda, et al.
Bone Marrow Transplantation|December 7, 2018
Safety and efficacy of rituximab-based first line treatment of chronic GVHDScott R Solomon, Connie A Sizemore, Michelle Ridgeway, et al.
Transplantation and Cellular Therapy|June 15, 2024
Impact of Graft-Versus-Host Disease on Relapse and Nonrelapse Mortality Following Posttransplant Cyclophosphamide-Based TransplantationScott R Solomon, Lizamarie Bachier-Rodriguez, Asad Bashey, et al.
Blood Advances|September 6, 2019
HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysisMohamad A Meybodi, Wenhao Cao, Leo Luznik, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 8, 2011
Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901Thomas Shea, Jeffrey Johnson, Peter Westervelt, et al.
Blood Advances|June 28, 2023
Phase 2 study of PD-1 blockade following autologous transplantation for patients with AML ineligible for allogeneic transplantScott R Solomon, Melhem Solh, Lawrence E Morris, et al.
Pageof 13

Showing results (31-40 of 128) with videos related to

Sort By:
Pageof 13
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 12, 2015
Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors: A Multivariable Analysis Including Disease Risk IndexAsad Bashey, Xu Zhang, Katelin Jackson, et al.
Blood Advances|October 27, 2020
Class II HLA mismatch improves outcomes following haploidentical transplantation with posttransplant cyclophosphamideScott R Solomon, Michael T Aubrey, Xu Zhang, et al.
Bone Marrow Transplantation|March 11, 2018
Comparison of outcomes following transplantation with T-replete HLA-haploidentical donors using post-transplant cyclophosphamide to matched related and unrelated donors for patients with AML and MDS aged 60 years or olderZain A Bashey, Xu Zhang, Stacey Brown, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2015
Corticosteroid-Free Primary Treatment of Chronic Extensive Graft-versus-Host Disease Incorporating RituximabScott R Solomon, Connie A Sizemore, Michelle Ridgeway, et al.
Transplantation and Cellular Therapy|May 22, 2022
High-Dose Bendamustine, Etoposide, Cytarabine, and Melphalan (BeEAM) Conditioning Before Autologous Transplantation for Patients With Multiple MyelomaScott R Solomon, Stacey Brown, Nancy Shegda, et al.
Bone Marrow Transplantation|December 7, 2018
Safety and efficacy of rituximab-based first line treatment of chronic GVHDScott R Solomon, Connie A Sizemore, Michelle Ridgeway, et al.
Transplantation and Cellular Therapy|June 15, 2024
Impact of Graft-Versus-Host Disease on Relapse and Nonrelapse Mortality Following Posttransplant Cyclophosphamide-Based TransplantationScott R Solomon, Lizamarie Bachier-Rodriguez, Asad Bashey, et al.
Blood Advances|September 6, 2019
HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysisMohamad A Meybodi, Wenhao Cao, Leo Luznik, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 8, 2011
Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901Thomas Shea, Jeffrey Johnson, Peter Westervelt, et al.
Blood Advances|June 28, 2023
Phase 2 study of PD-1 blockade following autologous transplantation for patients with AML ineligible for allogeneic transplantScott R Solomon, Melhem Solh, Lawrence E Morris, et al.
Pageof 13